Year: 2025

FDA issues Complete Response Letter (CRL) for resubmitted ONS-5010 BLA ISELIN, N.J., Dec. 31, 2025 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) to the ONS-5010/LYTENAVA™ (bevacizumab-vikg) biologics license application (BLA) resubmission, indicating that the FDA cannot approve the application in its present form for the treatment of wet age-related macular degeneration (wet AMD). In the CRL, the FDA noted that the additional mechanistic and natural history data information provided in the BLA resubmission does not alter the previous review conclusion that while the one adequate...

CALGARY, Alberta, Dec. 31, 2025 (GLOBE NEWSWIRE) — Wilmington Capital Management Inc. (TSX: WCM.A, WCM.B) (“Wilmington” or the “Corporation”) today announced changes to its Board of Directors. The Corporation announced that Messrs. Joseph Killi, Christopher Killi and Marc Sardachuk stepped down from their respective roles as Directors, and where applicable, as Officers of the Corporation. These changes are part of a transition plan previously announced, and the Board thanks them for their service and significant contributions to the Corporation during their tenure. The Corporation also announced the appointment of Messrs. Irfhan Rawji, Francis Cooke and Matt Rachiele to the Board of Directors effective the same date. The new directors bring a diverse range of experience which the Corporation believes will support its strategy for...

SHENZHEN, China, Dec. 31, 2025 (GLOBE NEWSWIRE) — UTime Limited (Nasdaq: WTO), a global technology company engaged in the design and development of mobile devices today announced a major commercial breakthrough. UTime’s Hong Kong subsidiary, UTime Technology (HK) Company Limited, has officially signed a smart health device procurement agreement worth nearly $10 million USD with Tumu Vertex LLC, a Denver-based entity, marking a crucial step in UTime’s strategic deployment in the North American medical-grade smart wearable market. Under the signed Sales Agreement, Tumu Vertex LLC has placed an initial purchase order for 50,000 premium smart health devices from UTime, comprising:25,000 units of the UT-168 BT Blood Pressure Watch and 25,000 units of the UR08 ECG Smart Ring.25,000 units of the UT-368 4G Blood Pressure Watch...

EDMONTON, Alberta, Dec. 31, 2025 (GLOBE NEWSWIRE) — Regenx Tech Corp., (the “Company” or “Regenx“) (CSE: RGX) (OTCQB: RGXTF) (FSE: YRS WKN: A2DSW3) announces that it has received unsecured and non-brokered financing for gross proceeds of $352,834 in Debenture Financing. The debentures will bear interest at the rate of 25% per annum. The Corporation can redeem the Debentures at any time upon 10 days prior written notice. The Company intends to use the proceeds to support operations, and general working capital. About Regenx Regenx Tech is a cleantech, urban mining company that recycles end-of-life diesel catalytic converters using its innovative and environmentally friendly proprietary technology for the recovery of precious metals, such as platinum and palladium. Learn more at www.regenx.tech.For further...

SINGAPORE, Dec. 31, 2025 (GLOBE NEWSWIRE) — Fitness Champs Holdings Limited (“Fitness Champs Holdings”, “FCHL” or the “Company”) (NASDAQ: FCHL), a distinguished aquatic sports education provider in Singapore, will hold an Extraordinary General Meeting of Shareholders (the “EGM”) at 7030 Ang Mo Kio Street, Avenue 5, #04-48, North Star@AMK, Singapore at 10 a.m. (Singapore Time) on January 23, 2026 (9 p.m. Eastern Standard Time on January 22, 2026). Holders of the Company’s ordinary shares listed in the register of members of the Company at the close of business on December 30, 2025 (Singapore Time) are entitled to receive notice of, and vote at, the EGM or at any adjournment or postponement that may take place. Copies of the Notice of the EGM, which sets forth the resolutions to be proposed and for which adoption from shareholders...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 31, 2025 (GLOBE NEWSWIRE) — Copper Road Resources Inc. (TSX-V: CRD) (“Copper Road Resources” or the “Company“) is pleased to announce that it has closed the second and final tranche (the “Second Tranche”) of its previously announced non-brokered private placement (the “Offering”) consisting of the sale of: (i) 3,380,889 flow-through units ( the “FT Units”) at a price of $0.045 per FT Unit, (ii) 2,700,000 flow-through units at a price of $0.05 per FT Unit, and (iii) 6,312,500 hard-dollar units (the “Units”) at a price of $0.04 per Unit for aggregate gross proceeds of $539,640. Each Unit consists of one common share of the Company and one common share purchase warrant (each, a “Warrant”). Each FT...

GRAND RAPIDS, Mich., Dec. 31, 2025 (GLOBE NEWSWIRE) — Independent Bank Corporation (NASDAQ: IBCP), the holding company of Independent Bank, a Michigan-based community bank, announced that it expects to issue its 2025 fourth quarter results on Thursday, January 22, 2026, at approximately 8:00 am ET. The release will be available on the Internet at IndependentBank.com within the “News” section of the “Investor Relations” area of the Company’s website. Brad Kessel, President and CEO, Gavin Mohr, CFO and Joel Rahn, EVP Commercial Banking will review the quarterly results in a conference call for investors and analysts beginning at 11:00 am ET on Thursday, January 22, 2026. To access via phone, participants will need to register using the following link where they will be provided a phone number and access code: https://register-conf.media-server.com/register/BIda5dc0f6055c4175bbaa1e1fddbc12fa In...

PERTH, AUSTRALIA, Dec. 31, 2025 (GLOBE NEWSWIRE) — Globavend Holdings Limited (“Globavend” or the “Company”) (NASDAQ: GVH), an emerging e-commerce logistics provider, announced the pricing of a public offering with gross proceeds to the Company of approximately $1.4 million, before deducting placement agent fees and other estimated expenses payable by the Company. The offering is comprised of 889,359 of the Company’s ordinary shares or pre-funded warrants to purchase ordinary shares. The effective purchase price per ordinary share is $1.60. The Company intends to use the net proceeds from this offering for working capital and general corporate purposes. The offering is expected to close on January 2, 2026. Univest Securities, LLC is acting as sole placement agent for the offering. The securities described above are being offered...